| An integrated genomic analysis of human glioblastoma multiforme DW Parsons, S Jones, X Zhang, JCH Lin, RJ Leary, P Angenendt, ... science 321 (5897), 1807-1812, 2008 | 6843 | 2008 |
| The genetic landscape of the childhood cancer medulloblastoma DW Parsons, M Li, X Zhang, S Jones, RJ Leary, JCH Lin, SM Boca, ... science 331 (6016), 435-439, 2011 | 809 | 2011 |
| The integrated landscape of driver genomic alterations in glioblastoma V Frattini, V Trifonov, JM Chan, A Castano, M Lia, F Abate, ST Keir, AX Ji, ... Nature genetics 45 (10), 1141-1149, 2013 | 588 | 2013 |
| The pediatric preclinical testing program: description of models and early testing results PJ Houghton, CL Morton, C Tucker, D Payne, E Favours, C Cole, ... Pediatric blood & cancer 49 (7), 928-940, 2007 | 499 | 2007 |
| Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas PJ Killela, CJ Pirozzi, P Healy, ZJ Reitman, E Lipp, BA Rasheed, R Yang, ... Oncotarget 5 (6), 1515, 2014 | 293 | 2014 |
| Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001 … RK Goudar, Q Shi, MD Hjelmeland, ST Keir, RE McLendon, CJ Wikstrand, ... Molecular cancer therapeutics 4 (1), 101-112, 2005 | 290 | 2005 |
| Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP) JM Maris, CL Morton, R Gorlick, EA Kolb, R Lock, H Carol, ST Keir, ... Pediatric blood & cancer 55 (1), 26-34, 2010 | 263 | 2010 |
| Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer LW Jones, BL Viglianti, JA Tashjian, SM Kothadia, ST Keir, SJ Freedland, ... Journal of applied physiology 108 (2), 343-348, 2010 | 239 | 2010 |
| Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF‐1 receptor by the pediatric preclinical testing program EA Kolb, R Gorlick, PJ Houghton, CL Morton, R Lock, H Carol, ... Pediatric blood & cancer 50 (6), 1190-1197, 2008 | 212 | 2008 |
| A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth Q Shi, AB Hjelmeland, ST Keir, L Song, S Wickman, D Jackson, O Ohmori, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 2007 | 210 | 2007 |
| Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program PJ Houghton, CL Morton, EA Kolb, R Gorlick, R Lock, H Carol, ... Pediatric blood & cancer 50 (4), 799-805, 2008 | 206 | 2008 |
| Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling SC Mack, KW Pajtler, L Chavez, K Okonechnikov, KC Bertrand, X Wang, ... Nature 553 (7686), 101-105, 2018 | 195 | 2018 |
| Activity of temozolomide in the treatment of central nervous system tumor xenografts HS Friedman, ME Dolan, AE Pegg, S Marcelli, S Keir, JJ Catino, ... Cancer research 55 (13), 2853-2857, 1995 | 179 | 1995 |
| Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft HS Friedman, SP Johnson, Q Dong, SC Schold, BKA Rasheed, ... Cancer research 57 (14), 2933-2936, 1997 | 177 | 1997 |
| Poly (ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft CL Cheng, SP Johnson, ST Keir, JA Quinn, F Ali-Osman, C Szabo, H Li, ... Molecular cancer therapeutics 4 (9), 1364-1368, 2005 | 167 | 2005 |
| Initial testing (stage 1) of the BH3 mimetic ABT‐263 by the pediatric preclinical testing program R Lock, H Carol, PJ Houghton, CL Morton, EA Kolb, R Gorlick, ... Pediatric blood & cancer 50 (6), 1181-1189, 2008 | 153 | 2008 |
| KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation C Guo, LH Chen, Y Huang, CC Chang, P Wang, CJ Pirozzi, X Qin, X Bao, ... Oncotarget 4 (11), 2144, 2013 | 151 | 2013 |
| Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program PJ Houghton, CL Morton, EA Kolb, R Lock, H Carol, CP Reynolds, ... Pediatric blood & cancer 50 (1), 37-45, 2008 | 145 | 2008 |
| Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program JM Maris, J Courtright, PJ Houghton, CL Morton, R Gorlick, EA Kolb, ... Pediatric blood & cancer 50 (3), 581-587, 2008 | 133 | 2008 |
| Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing program MA Smith, CP Reynolds, MH Kang, EA Kolb, R Gorlick, H Carol, RB Lock, ... Clinical Cancer Research 21 (4), 819-832, 2015 | 128 | 2015 |
